Moderna shares surge after FDA approves coronavirus vaccine for phase 2 trial 0 07.05.2020 15:52 CNBC The race to develop anything to fight the coronavirus is intensely competitive and investors are watching closely for signs of progress on treatments and vaccines. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
